Page last updated: 2024-10-30

leflunomide and Hepatitis E

leflunomide has been researched along with Hepatitis E in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Research Excerpts

ExcerptRelevanceReference
"Leflunomide was stopped and restarted 5 months after the initial diagnosis at the same dosage, with a close clinical and laboratory follow-up."5.51Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology. ( Carubbi, F; Cipriani, P; Di Bartolomeo, S; Giacomelli, R; Grimaldi, A; Marola, L; Picchi, G; Ricciardi, A, 2019)
"Leflunomide was stopped and restarted 5 months after the initial diagnosis at the same dosage, with a close clinical and laboratory follow-up."1.51Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology. ( Carubbi, F; Cipriani, P; Di Bartolomeo, S; Giacomelli, R; Grimaldi, A; Marola, L; Picchi, G; Ricciardi, A, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carubbi, F1
Picchi, G1
Di Bartolomeo, S1
Ricciardi, A1
Cipriani, P1
Marola, L1
Grimaldi, A1
Giacomelli, R1

Other Studies

1 other study available for leflunomide and Hepatitis E

ArticleYear
Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology.
    Medicine, 2019, Volume: 98, Issue:33

    Topics: Adult; Arthritis, Rheumatoid; Female; Hepatitis E; Hepatitis E virus; Humans; Immunosuppressive Agen

2019